Marco Thomann

Marco Thomann

Company: Roche

Job title: Principal Scientist - Gene Therapy & Technical Development Analytics


Advancing CQA Assessments for Gene Therapy 1:05 pm

Ensuring that novel CQAs (Critical Quality Attributes) for gene therapies are addressed is pivotal in ensuring the safety, efficacy, and consistency of emerging products. This workshop will take a look at some of the less conventional CQAs and assess their relative importance when planning an early analytical strategy. This workshop will set out to include:…Read more

day: Pre-Conference Workshop Day

PANEL DISCUSSION: Choosing a Method Of Empty-Full Characterisation. How Do We Ensure Industry Standardisation? 1:30 pm

Discussing best practice for empty-full characterisations, including AUC, HPLC, and ELISAs Considering the balance of cost, accuracy, reproducibility, speed, and precision Discussing whether methods ensure GMP during commercial upscaling Risk/Benefit ratio of investing in one vs multiple analytical tools Read more

day: Day One Track B PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.